IP Verse

Scalable Purification Method For Aav9 - EP3387138

The patent EP3387138 was granted to The Trustees OF The University OF Pennsylvania on Jan 26, 2022. The application was originally filed on Dec 9, 2016 under application number EP16884241A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3387138

THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
Application Number
EP16884241A
Filing Date
Dec 9, 2016
Status
Granted And Under Opposition
Dec 24, 2021
Grant Date
Jan 26, 2022
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

JAMES POOLEOct 25, 2022CARPMAELS & RANSFORDADMISSIBLE

Patent Citations (24) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS2004110266
DESCRIPTIONUS2005024467
DESCRIPTIONUS2013045186
DESCRIPTIONUS2015349911
DESCRIPTIONUS5658785
DESCRIPTIONUS6566118
DESCRIPTIONUS6723551
DESCRIPTIONUS7906111
DESCRIPTIONUS8927514
DESCRIPTIONUS9102949
DESCRIPTIONWO2005033321
DESCRIPTIONWO2016049230
DESCRIPTIONWO9911764
DESCRIPTIONWO9915685
INTERNATIONAL-SEARCH-REPORTWO2004113494
INTERNATIONAL-SEARCH-REPORTWO2016200543
OPPOSITIONWO2004113494
OPPOSITIONWO2007127264
OPPOSITIONWO2009088786
OPPOSITIONWO2009108274
OPPOSITIONWO2011094198
OPPOSITIONWO2012112832
OPPOSITIONWO2014125101
OPPOSITIONWO2016200543

Non-Patent Literature (NPL) Citations (37) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
DESCRIPTION- BRUMENT, N et al., Mol Ther, (20020000), vol. 6, pages 678 - 686
DESCRIPTION- DAVIDOFF, AM et al., J Virol Methods, (20040000), vol. 121, pages 209 - 215
DESCRIPTION- DL THOMAS et al., Hum Gene Ther, (20090800), vol. 20, pages 861 - 870
DESCRIPTION- F. MINGOZZI et al., Sci Transl med., (20130717), vol. 5, no. 194
DESCRIPTION- GAO et al., Proc. Natl. Acad. Sci. U.S.A., (20030000), vol. 100, no. 10, pages 6081 - 6086
DESCRIPTION- GRIMM et al., Gene Therapy, (19990000), vol. 6, pages 1322 - 1330
DESCRIPTION- G YE et al., Hu Gene Ther Clin Dev, (20141200), vol. 25, pages 212 - 217
DESCRIPTION- HELLSTROM, M et al., Gene Ther, (20090000), vol. 16, pages 521 - 532
DESCRIPTION- J. D. THOMSON et al., "A comprehensive comparison of multiple sequence alignments", Nucl. Acids Res., (19990000), vol. 27, no. 13, pages 2682 - 2690
DESCRIPTION- KALUDOV et al., Hum. Gene Therapy, (20020000), vol. 13, pages 1235 - 1243
DESCRIPTION- KALUDOV, N et al., Hum Gene Ther, (20020000), vol. 13, pages 1235 - 1243
DESCRIPTION- LOCK et al., Hum Gene Ther, (20100000), vol. 21, no. 1, pages 1259 - 1271
DESCRIPTION- M, LOCK et al., "Hu Gene Therapy Methods", Hum Gene Ther Methods, (20140214), vol. 25, no. 2, pages 115 - 25
DESCRIPTION- M. MIETZSCH et al., Hum Gene Therapy, (20140300), vol. 25, pages 212 - 222
DESCRIPTION- M. POTTER et al., Molecular Therapy - Methods & Clinical Development, (20140000), vol. 1, no. 14034, pages 1 - 8
DESCRIPTION- M. URABE et al., Molecular Therapy, (20060400), vol. 13, no. 4, pages 823 - 828
DESCRIPTION- N. CLEMENT et al., Hum Gene Therapy, (20090800), vol. 20, pages 796 - 806
DESCRIPTION- OKADA, T et al., Hum Gene Ther, (20090000), vol. 20, pages 1013 - 1021
DESCRIPTION- RM KOTIN, Hu Mol Genet, (20110000), vol. 20, no. 1, pages R2 - R6
DESCRIPTION- R. PAUL et al., HUMAN GENE THERAPY, (19930000), vol. 4, pages 609 - 615
DESCRIPTION- SAMBROOK et al., Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Press
DESCRIPTION- SOMMER et al., Molec. Ther., (20030000), vol. 7, pages 122 - 128
DESCRIPTION- T VIRAG et al., Hu Gene Therapy, (20090800), vol. 20, pages 807 - 817
DESCRIPTION- WOBUS et al., J. Virol., (20000000), vol. 74, pages 9281 - 9293
DESCRIPTION- ZOLOTUKHIN et al., Methods, (20020000), vol. 28, no. 2, pages 158 - 167
DESCRIPTION- ZOLOTUKHIN, S et al., Methods, (20020000), vol. 28, pages 158 - 167
INTERNATIONAL-SEARCH-REPORT- QU ET AL, "Separation of adeno-associated virus type 2 empty particles from genome containing vectors by anion-exchange column chromatography", JOURNAL OF VIROLOGICAL MET, ELSEVIER BV, NL, (20070202), vol. 140, no. 1-2, doi:10.1016/J.JVIROMET.2006.11.019, ISSN 0166-0934, pages 183 - 192, XP005870426 [Y] 1-11 * abstract * * page 185, column l, paragraph l - column r, paragraph 1 * * page 184, column r, paragraph 2 * [A] 12-30
INTERNATIONAL-SEARCH-REPORT- KALUDOV N ET AL, "Scalable purification of adeno-associated virus type 2, 4, or 5 using ion-exchange chromatography", HUMAN GENE THERAPY, MARY ANN LIEBERT, INC. PUBLISHERS, US, (20020701), vol. 13, no. 10, doi:10.1089/104303402320139014, ISSN 1043-0342, pages 1235 - 1243, XP002382732 [I] 12-21 * abstract * * page 1236, column l, paragraph l - column r, paragraph 1 * * table 2 * * page 1239, column r, paragraph 1 - page 1240, column l * [A] 22-30 [Y] 1-11
OPPOSITION- Ge Healthcare, "Ion Exchange Chromatography & Chromatofocusing Principles and Methods", GE HEALTHCARE- Product handbook, (20100401), pages 1 - 60, XP055601234
OPPOSITION- VĂ©ronique Blouin et al, "Improving rAAV production and purification: towards the definition of a scaleable process", The Journal of Gene Medicine, (20040201), vol. 6, no. S1, doi:10.1002/jgm.505, ISSN 1099498X, pages S223 - S228, XP055182384
OPPOSITION- Qu Weihong et al, "Calcium-ion-modulated ceramic hydroxyapatite resin for the scalable purification of recombinant Adeno-Associated Virus serotype 9", Journal of Chromatography B, NL , (20150501), vol. 990, doi:10.1016/j.jchromb.2015.03.003, ISSN 1570-0232, pages 15 - 22, XP055840293
OPPOSITION- Qu, G. et al, "Separation of adeno-associated virus type 2 empty particles from genome containing vectors by anion-exchange column chromatography", Journal of virological methods, NL , (20070202), vol. 140, no. 1-2, doi:10.1016/j.jviromet.2006.11.019, ISSN 0166-0934, pages 183 - 192, XP005870426
OPPOSITION- Urabe, M.et al, "Removal of Empty Capsids from Type 1 Adeno-Associated Virus Vector Stocks by Anion-Exchange Chromatography Potentiates Transgene Expression", Molecular Therapy, US , (20060401), vol. 13, no. 4, doi:10.1016/j.ymthe.2005.11.024, ISSN 1525-0016, pages 823 - 828, XP005358617
OPPOSITION- SOMMER J M, ET AL., "Quantification of adeno-associated virus particles and empty capsids by optical density measurement", Molecular Therapy, US , (20030101), vol. 7, no. 1, doi:10.1016/S1525-0016(02)00019-9, ISSN 1525-0016, pages 122 - 128, XP002965707
OPPOSITION- KALUDOV N, HANDELMAN B, CHIORINI J A, "Scalable purification of adeno-associated virus type 2, 4, or 5 using ion-exchange chromatography", HUMAN GENE THERAPY, GB , (20020701), vol. 13, no. 10, doi:10.1089/104303402320139014, ISSN 1043-0342, pages 1235 - 1243, XP002382732
OPPOSITION- Martin Lock, Alvira Mauricio R., Wilson James M., "Analysis of Particle Content of Recombinant Adeno-Associated Virus Serotype 8 Vectors by Ion-Exchange Chromatography", Human Gene Therapy Methods, (20120201), vol. 23, no. 1, doi:10.1089/hgtb.2011.217, ISSN 1946-6536, pages 56 - 64, XP055349796
OPPOSITION- Otto-Wilhelm Merten, "AAV vector production: state of the art developments and remaining challenges", Cell and Gene Therapy Insights, (20161201), vol. 2, no. 5, doi:10.18609/cgti.2016.067, ISSN 2059-7800, pages 521 - 551, XP055649764

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents